Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,627,331
  • Shares Outstanding, K 143,251
  • Annual Sales, $ 118,190 K
  • Annual Income, $ -121,000 K
  • 60-Month Beta 1.80
  • Price/Sales 13.61
  • Price/Cash Flow N/A
  • Price/Book 3.19
Trade SGMO with:

Options Overview

Details
  • Implied Volatility 79.03%
  • Historical Volatility 55.16%
  • IV Percentile 62%
  • IV Rank 18.51%
  • IV High 182.15% on 03/12/20
  • IV Low 55.61% on 05/22/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 32
  • Volume Avg (30-Day) 1,601
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 8,199
  • Open Int (30-Day) 30,315

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.28
  • Number of Estimates 7
  • High Estimate -0.14
  • Low Estimate -0.51
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +24.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.51 +3.52%
on 03/05/21
15.45 -29.60%
on 02/09/21
-4.44 (-28.98%)
since 02/08/21
3-Month
9.64 +12.83%
on 12/09/20
19.43 -44.00%
on 12/28/20
+1.20 (+12.40%)
since 12/08/20
52-Week
4.81 +126.20%
on 03/17/20
19.43 -44.00%
on 12/28/20
+2.63 (+31.88%)
since 03/06/20

Most Recent Stories

More News
Stock Market News for Feb 26, 2021

U.S. stock markets closed sharply lower on Thursday as rising bond yields raised concerns among market participants on risky assets like equities

PZZA : 79.36 (-4.00%)
SGMO : 10.88 (-4.23%)
TDOC : 176.65 (-6.87%)
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Lags Revenue Estimates

Sangamo (SGMO) delivered earnings and revenue surprises of -61.11% and -31.44%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

SGMO : 10.88 (-4.23%)
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported fourth quarter and full year 2020 financial results and recent business highlights.

SGMO : 10.88 (-4.23%)
Sangamo Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Sangamo Therapeutics, Inc. (NASDAQ:SGMO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24,...

SGMO : 10.88 (-4.23%)
Oversold Conditions For Sangamo Therapeutics (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

SGMO : 10.88 (-4.23%)
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

SGMO : 10.88 (-4.23%)
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2020 Conference Call and Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its fourth quarter and full year 2020 financial results after the market...

SGMO : 10.88 (-4.23%)
Sangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as Head of Development; Elevates Jason Fontenot, PhD to Chief Scientific Officer

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Rob Schott, MD, MPH, FACC, as Senior Vice President and Head of Development. Dr. Schott will lead...

SGMO : 10.88 (-4.23%)
Sangamo Therapeu Shares Up 43.0% Since SmarTrend's Buy Recommendation (SGMO)

SmarTrend identified an Uptrend for Sangamo Therapeu (NASDAQ:SGMO) on October 12th, 2020 at $11.02. In approximately 3 months, Sangamo Therapeu has returned 42.99% as of today's recent price of $15.75....

SGMO : 10.88 (-4.23%)
BioMarin (BMRN) Reveals 1-Year Data on Hemophilia Gene Therapy

BioMarin (BMRN) announces one-year update from GENEr8-1 phase III study, which shows that valoctocogene roxaparvovec significantly reduces annualized bleeding rate (ABR) by 84% in patients with hemophilia...

RHHBY : 40.1200 (-1.16%)
PFE : 34.35 (-0.12%)
BMRN : 76.59 (-1.47%)
SGMO : 10.88 (-4.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 12.25
2nd Resistance Point 11.96
1st Resistance Point 11.42
Last Price 10.88
1st Support Level 10.59
2nd Support Level 10.30
3rd Support Level 9.76

See More

52-Week High 19.43
Fibonacci 61.8% 13.85
Fibonacci 50% 12.12
Last Price 10.88
Fibonacci 38.2% 10.39
52-Week Low 4.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar